The malaria parasite multiplies in red blood cells, safe from our immune defences
Monkey tests hint compound could paralyse malaria parasite in humans.
A new-found chemical can root out malaria parasites hiding in red blood cells and stop them reproducing. It may become a much-needed new weapon in the war against one of the world’s biggest killers.
The compound clears monkeys of infection with the human malaria parasite Plasmodium falciparum at doses far lower than existing antimalarial drugs. But testing in humans is a few years away at least, says Henri Vial at Montpellier University in France who discovered the 1.
Vial’s team developed a range of compounds that interfere with the building of cell membranes. Rapidly reproducing parasites are constantly making new cell membranes.
They used infected human blood samples to screen all their chemicals for antimalarial activity. A compound with the working name G25 came out on top.
"We were very lucky," says Vial: G25 only enters red-blood cells that harbour reproducing malaria parasites. Why is a mystery, and "the focus of our research now", Vial says.
This selectivity is important for two reasons. First, because all animal cells make membranes, G25 would be highly toxic if it were less discerning. More importantly, scientists could exploit the chemical’s nose for malaria-infected cells to deliver other antimalarial compounds. "It is a natural targeting mechanism," Vial says.
"No other group of drugs works like this," says Peter Winstanley, who is developing new antimalarial drugs at the University of Liverpool in England. As a result, he hopes G25 could kill even drug-resistant malaria.
But because G25 acts on a fundamental biological system there could be harmful side-effects. Vial’s team saw nothing untoward in monkeys, but admits more work on the safety of the compound is needed.
Another big hurdle is getting the compound into pill form. Currently it has to be injected. "We do have problems with oral absorption," says Vial. Chemical tweaking of G25 should help.
Scientific obstacles aside, new malaria drugs face an uphill economic struggle, cautions Winstanley. To save the most lives, malaria drugs must be affordable for developing countries where the disease is endemic. Keeping development costs low enough to achieve this is hard.
The newest antimalarial drug on the market costs $57 for a course of treatment. For the developing world "it would need to cost a lot less than 50 cents", Winstanley says.
TOM CLARKE | © Nature News Service
Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena
Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Power and Electrical Engineering
15.12.2017 | Materials Sciences
15.12.2017 | Life Sciences